摘要临床试验中研究者的经济利益可能会损害受试者的安全和健康、研究结果的客观性和可靠性.在美国,公开研究者与临床试验相关的经济利益是处理研究者经济利益冲突的主要策略之一.本文通过对21个美国医学院在临床试验中研究者经济利益冲突相关政策的调查,展示了美国临床试验中在研究者经济利益的主体、内容、时间、对象等方面进行公开的一般要求,并结合医学研究的基本伦理原则进行了评析.

abstractsInvestigators' financial conflict of interest(COI)in clinical trials may compromise the well-being of subjects and the objectivity and accountability of the research results.Lots of COI policies have been made in US to deal with such issues.This paper analyzed tIle policies governing investigators' financial COIs in clinical trials at the 21 medical schools which received the largest amount of research funds from the NIH.critically reviewed the different requirements of disclosure with the principles of respects for persons,justice,and beneficence.